SecBot SecBot
144 ·Filed May 14, 2026

RPRX

Royalty Pharma plc
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago SEC0001964306-26-000240
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale of a small number of shares acquired through equity compensation. No material signal for the stock. Monitor for any larger insider sales or changes in insider sentiment in future filings.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$52.85
T+0 close · May 14, 2026 · via day close
Latest settled
+9.35%
T+60 · $57.79
Vs SPY
+4.83%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 15 $52.85entry
  2. T+1 · 6mo ago −1.48%α −1.41% · $52.07
  3. T+5 · 6mo ago +3.12%α +2.16% · $54.50
  4. T+20 · 5mo ago +2.69%α +0.57% · $54.27
  5. T+60 · 3mo ago +9.35%α +4.83% · $57.79
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Gregory Norden, an officer of Royalty Pharma, filed a Form 144 on May 14, 2026, indicating intent to sell 3,045 shares of common stock with an approximate market value of $161,385. The shares were acquired via vesting of restricted stock units on May 13, 2026, and the sale is a routine, small-dollar transaction relative to the company's $30.7B market cap.

Key Facts

  • Filer: Gregory Norden (officer of Royalty Pharma)
  • Proposed sale: 3,045 shares of common stock
  • Approximate value: $161,385 (based on filing date price)
  • Shares acquired via RSU vesting on May 13, 2026
  • Sale intended to be executed through Merrill Lynch
  • Transaction size is ~0.0005% of Royalty Pharma's $30.7B market cap

Financial Impact

Proceeds of approximately $161,385, representing a negligible fraction of market cap

dilution

Risk Factors

  • Insider selling could be perceived negatively if it precedes a negative catalyst, but the small size here makes that unlikely

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001964306-26-000240
Document: 0001964306-26-000240-index.html0001964306-26-000240
Document: 0001964306-26-000240.txt0001964306-26-000240

Track record

23 reports on RPRX

Performance horizon

5 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +15.20% at T+60 after the May 6, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry price pending
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $67.57 to $68.97 Now $68.53 +1.41% ▲ +2.07% −1.22% vs SPY
  3. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  4. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $67.56 to $70.01 Now $68.53 +1.43% ▲ +3.63% +4.54% vs SPY
  5. Sep 30, 20266w ago Insider Cluster Bearish 5/10 Entry $57.63 to $56.21 Now $68.53 −18.91% ▲ +2.46% +3.77% vs SPY
  6. Sep 4, 202610w ago Press Release Bearish 5/10 Entry $60.59 to $58.47 Now $68.53 −13.10% ▲ +3.50% +2.38% vs SPY
  7. Aug 19, 202612w ago Insider Cluster Neutral 3/10 Entry $60.57 to $61.92 Now $68.53 +13.14% ▲ +2.24% +1.12% vs SPY
  8. Aug 12, 202613w ago 144 Neutral 3/10 Entry $58.56 to $60.58 Now $68.53 +17.02% ▲ +3.45% +5.41% vs SPY
  9. Aug 5, 202614w ago 8-K Bullish 6/10 Entry $57.75 to $59.22 Now $68.53 +18.66% ▲ +2.55% +2.19% vs SPY
  10. Jul 2, 202619w ago Insider Cluster Neutral 2/10 Entry $57.77 to $57.96 Now $68.53 +18.62% ▲ +0.33% −0.60% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (11h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 14, 2026